FDA rejects Merck's Vioxx successor
(AP)
<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20070427/ap_on_he_me/merck_vioxx_successor"><img src="http://d.yimg.com/us.yimg.com/p/nm/20070419/2007_04_19t074438_450x300_us_merck_results.jpg?x=130&y=86&sig=ov6BXBS3dyEDEios6VjtUw--" align="left" height="86" width="130" alt="The Merck and Co. logo in a fil photo. The company said on Thursday first-quarter earnings rose as booming sales of newer prescription drugs offset declines in older products such as its Zocor cholesterol fighter. (Tami Chappell/Reuters)" border="0" /></a>AP - The Food and Drug Administration rejected Merck & Co.'s request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drugmaker said Friday.</p><br clear="all"/>

Read more...